Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Sruthi Arepalli, MD, spotlights a deep-dive orbital tour of the eye
To learn more about or to register for EyeCon 2025, click here. Set against the backdrop of a scenic Florida coastline and a growing emphasis on cross-specialty collaboration in eye care, the Ophthalmology Times and Optometry Times EyeCon® 2025 conference is…
Effects of calcium channel blockers on visual field progression in glaucoma patients
(Image credit: AdobeStock) Researchers from UK and Italian institutions investigated the association between the effects of calcium channel blockers and the rate of visual field (VF) progression in patients with glaucoma. First author Giovanni Montesano, MD, PhD, and colleagues reported…
Study links AMD to higher cardiovascular disease mortality in high-risk patients
Australian researchers identified in a recent study an association between age-related macular degeneration (AMD) and cardiovascular disease (CVD): they showed that the presence of AMD predicted an increased risk of all-cause and CVD mortality in patients with a high risk…
Global Spotlight: The Most Cost-Effective Countries for Cataract Surgery
Cataract surgery remains one of the most common and effective ophthalmic procedures globally, but the cost can be a significant barrier for many patients. In an increasingly interconnected world, medical tourism has emerged as a viable solution, offering high-quality, affordable…
Sandoz and Regeneron reach agreement over biosimilar dispute
(Image Credit: AdobeStock) Sandoz and Regeneron Pharmaceuticals have announced an agreement settling all patent disputes between the 2 companies relating to the US Food and Drug Administration (FDA)-approved Sandoz aflibercept biosimilar. Sandoz received FDA approval for its biosimilar Enzeevu (aflibercept-abzv)…
Using OCT-A to explore biomarkers for neurodegenerative diseases
Amir H. Kashani, MD, PhD, a professor of ophthalmology at Johns Hopkins University, discussed a significant research publication in Alzheimers and Dementia that explored OCT-A angiography’s potential in studying neurodegenerative diseases. The study focused on developing a consensus method for…
UnitedHealthcare updates Glaucoma Surgical Treatments policy
(Image Credit: AdobeStock/gguy) UnitedHealthcare (UHC) has updated its Glaucoma Surgical Treatments policy to include goniotomy, trabeculotomy, canaloplasty (ab interno), combined canaloplasty (ab interno), and trabeculotomy procedures when deemed medically necessary for treating mild to moderate open-angle glaucoma (OAG) and cataracts…
Beacon Therapeutics reports positive phase 2 results for gene therapy in X-linked retinitis pigmentosa
(Image Credit: AdobeStock/Dmitrii Kotin) Beacon Therapeutics recently revealed topline data results for 2 of the company’s phase 2 trials—SKYLINE and DAWN, both investigating laruparetigene zovaparvovec (laru-zova) in patients with X-linked retinitis pigmentosa (XLRP).1 The data was presented during the 2025…
Positive topline data announced from AVONELLE-X and SALWEEN trials
(Image credit: ©pressmaster/AdobeStock) Roche recently announced new data from the AVONELLE-X and SALWEEN trials of Vabysmo (faricimab).1 These trial data were presented at the 25th European Society of Retina Specialists (EURETINA) Annual Congress held September 4-7 in Paris. Positive safety,…
Amir Kashani on biomarkers for Alzheimer disease
(Image credit: AdobeStock/Pixel Matrix) Amir H. Kashani, MD, PhD, is a professor of ophthalmology at the Wilmer Eye Institute in Johns Hopkins University in Baltimore, Maryland. In an interview with Ophthalmology Times, Kashani discussed a research paper on OCT-A angiography’s…